Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database

Adverse drug reactions (ADRs) are important causes of death. However, the main involved drugs are relatively unknown. The present study was performed to characterise death‐related drugs recorded in a large pharmacovigilance database during the last 10 years.

• Publication year

  2021

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2021-04-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.14851PMID 33837554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Uses of pharmacovigilance databases: An overview.

  2020cited by this paper
• Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies

  2019cited by this paper
• Case-non-case studies: Principle, methods, bias and interpretation.

  2019cited by this paper
• Pharmacovigilance - The next chapter.

  2019cited by this paper
• Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008–2013

  2019cited by this paper
• Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century

  2019cited by this paper
• Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

  2018cited by this paper
• Mortality from adverse drug reaction‐related hospitalizations in south‐west Ethiopia: A cross‐sectional study

  2018cited by this paper
• Mortality among patients due to adverse drug reactions that lead to hospitalization: a meta-analysis

  2018influential reference
• [Case-non case studies: Principles, methods, bias and interpretation].

  2017cited by this paper
• Trends in opioid analgesic abuse and mortality in the United States.

  2015cited by this paper
• Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study

  2015cited by this paper
• Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey.

  2015cited by this paper
• Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!

  2013cited by this paper
• Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database.

  2011cited by this paper
• Meta‐analysis of brain‐derived neurotrophic factor p.Val66Met in adult ADHD in four European populations

  2010cited by this paper
• BMC Clinical Pharmacology BioMed Central

  2009cited by this paper
• The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty

  2009cited by this paper
• Drug-Related Deaths

  2008cited by this paper
• Drug-related deaths: analysis of an Italian spontaneous reporting database.

  2006cited by this paper
• Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

  2004cited by this paper
• The cost of adverse drug reactions

  2003cited by this paper
• Admissions to hospital caused by adverse drug reactions: cross sectional incidence study

  2000cited by this paper
• Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974–1993, based on the data of Berne/St. Gallen

  2000cited by this paper
• Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres.

  2000cited by this paper
• The Medical Dictionary for Regulatory Activities (MedDRA)

  1999cited by this paper
• Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.

  1998cited by this paper

• Elevating Drug Safety Oversight: A Comprehensive Examination of Dynamic and Static Monitoring Systems across the United States, European Union, and India

  2026cites this paper
• CAKADE: Improving ADE Detection on Social Media with LLMs via Counterfactual Augmentation and Knowledge-Enhanced Instruction Tuning

  2025cites this paper
• Evaluating adverse events of antibacterials in infants: insights from FDA adverse event reporting system (FAERS) data.

  2025cites this paper
• Post-marketing surveillance of upadacitinib: multilevel analysis of venous thromboembolism reporting in global data and rheumatoid arthritis

  2025cites this paper
• Drug Risk Classification Model Based on Machine Learning

  2025cites this paper
• Idealized Framework for Assisting Pharmacovigilance Reporting in an Ambulatory Primary Care and Chronic Disease Management Clinic

  2025cites this paper
• Pharmacovigilance Signal Detection of Drug-Induced Hospitalizations and Mortality: A 5-Year Nationwide Study

  2025influential citation
• Detection of Adverse Medicine Events by Pharmacists in Residential Aged Care Facilities: Secondary Analysis of Data From ReMInDAR Trial

  2025cites this paper
• Understanding causes of incomplete reports of adverse drug reactions associated with dolutegravir-based HIV treatment in uganda: a qualitative study

  2025cites this paper
• Contemporary local anaesthetic-associated adverse events and mortality: searching for the root causes of the pharmacovigilance signal. Br J Anaesth 2025: S0007-0912(25)00493-3. doi: 10.1016/j.bja.2025.06.044b.

  2025cites this paper
• Polypharmacy, Drug-drug Interaction and Potentially Inappropriate Medication in Hospitalized Elderly Patients with Cardiovascular Diseases in Wangaya Hospital

  2025cites this paper
• ADENER: A syntax-augmented grid-tagging model for Adverse Drug Event extraction in social media

  2025cites this paper
• Fact-Finding Survey of Lethal or Fatal Adverse Drug Events in the Japanese Adverse Drug Event Report Database, Fiscal Year 2004–2023 (Adults ≥ 20 Years)

  2025cites this paper
• Building functional and sustainable pharmacovigilance systems: an analysis of pharmacovigilance development across high-, middle- and low-income countries

  2025cites this paper
• Adverse Drug Reaction Monitoring and Reporting in a Tertiary Care Teaching Hospital in Goa

  2025cites this paper
• Chemotherapy-related adverse drug reaction and associated factors among adult cancer patient attending Jimma medical center oncology unit, Southwest Ethiopia

  2025cites this paper
• Analyzing the Patterns of Adverse Drug Reactions Due to anti-infectives from large-scale nationwide database in Thailand.

  2025cites this paper
• Predictors of Adverse Drug Reaction Monitoring Practices Among Hospital Nurses

  2025cites this paper
• Beyond Acute Overdoses: A Case of Chronic Clozapine Toxicity With Non-specific Presentation

  2025cites this paper
• Fractures Associated with Immune Checkpoint Inhibitors: A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database

  2025cites this paper
• Comparative Analysis of Adverse Drug Reactions Associated with Fluoroquinolones and Other Antibiotics: A Retrospective Pharmacovigilance Study

  2025cites this paper
• Epidemiology of reported serious adverse drug reactions due to anti-infectives using nationwide database of Thailand

  2025cites this paper
• Risks of oral anticoagulants: Analysis of adverse drug reactions reported to the Portuguese National Pharmacovigilance System

  2024cites this paper
• Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS

  2024cites this paper
• Genetic diversity of variants involved in drug response among Tunisian and Italian populations toward personalized medicine

  2024cites this paper
• Digital Technology Applications in the Management of Adverse Drug Reactions: Bibliometric Analysis

  2024cites this paper
• Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis

  2024cites this paper
• Sex and gender differences and pharmacovigilance: a knot still to be untied

  2024cites this paper
• MedAlisto: A Collaborative Intervention Program with FDA-CDRR for Adverse Drug Effect Reporting Among Community Pharmacies in Davao City

  2024influential citation
• Mortality Rate Related to Adverse Drug Reactions in Iraqi Patients: A Study Based on WHO Database

  2024cites this paper
• The Clinical Impact of Hospital-Acquired Adverse Drug Reactions in Older Adults: An Australian Cohort Study.

  2024cites this paper
• Healthcare provider and patient perspectives on the implementation of pharmacogenetic-guided treatment in routine clinical practice

  2024cites this paper
• Research on Adverse Drug Reaction Prediction Model Combining Knowledge Graph Embedding and Deep Learning

  2024cites this paper
• Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors

  2024cites this paper
• Systematic Review and Meta-analysis on Effectiveness of Strategies for Enhancing Adverse Drug Reaction Reporting.

  2024cites this paper
• The pattern of adverse drug reactions at a National Cancer Hospital in Indonesia: Analysis of spontaneous reports from healthcare professionals

  2024influential citation
• Adverse Drug Reactions Reporting Profile in Tertiary Referral Hospital: A Retrospective Pharmacovigilance Study in Indonesia

  2024cites this paper
• Barriers and Facilitators on Pharmacovigilance Practice Among Pharmacists in Metro Manila, Philippines

  2024cites this paper
• Prevalence of adverse drug reactions associated with emergency department visits and risk factors for hospitalization.

  2023cites this paper
• Development and Verification of Time-Series Deep Learning for Drug-Induced Liver Injury Detection in Patients Taking Angiotensin II Receptor Blockers: A Multicenter Distributed Research Network Approach

  2023cites this paper
• Metabophore-mediated retro-metabolic ('MeMeReMe') approach in drug design.

  2023cites this paper
• Why is the Safety of Medicines Important for Resilient Health Systems? A Synthesis Report

  2023cites this paper
• Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022

  2023cites this paper
• Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia

  2023cites this paper
• Yatan Hastalarda Raporlanan Advers İlaç Reaksiyonlarının Değerlendirilmesi

  2023cites this paper
• Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK.

  2023influential citation
• Drug-induced diseases: A worrying, neglected, preventable, serious and costly epidemic.

  2023cites this paper
• Towards more accurate pharmacogenomic variant effect predictions.

  2023cites this paper
• Drug‐related deaths in a university hospital: Comparison to previous decades

  2023cites this paper
• Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia).

  2023cites this paper
• A national pharmacovigilance study of haematological adverse drug reactions to clozapine vs other second-generation antipsychotics in Italy.

  2023cites this paper
• Current Status and Challenges of Pharmacovigilance of Traditional Medicines in French-Speaking West African (UEMOA) Countries

  2023cites this paper
• Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: A nationwide, repeated cross-sectional study.

  2023cites this paper
• Escaping the Long Shadow Cast by Agranulocytosis

  2023cites this paper
• Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing

  2023cites this paper
• Fatal adverse drug reactions in children: A descriptive study in the World Health Organization pharmacovigilance database, 2010–2019

  2022influential citation
• Advances in Our Understanding of the Interaction of Drugs with T-cells: Implications for the Discovery of Biomarkers in Severe Cutaneous Drug Reactions.

  2022cites this paper
• Sex differences in serious adverse drug reactions in patients receiving immunotherapy, targeted therapy, or chemotherapy: a disproportionality analysis of the VigiBase®

  2022cites this paper
• Coriell Life Sciences: empowering the most precise medical care for a healthier world.

  2022cites this paper
• Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study

  2022cites this paper
• Quo vadis (where are you going) pharmacovigilance?

  2022cites this paper
• Potential safety signals for antibacterial agents from the Brazilian national pharmacovigilance database (Vigimed/VigiFlow)

  2022cites this paper
• According to the WHO clozapine pharmacovigilance database, the United Kingdom accounts for 968 fatal outcomes versus 892 in the rest of the world

  2022influential citation
• Time-Trends of Drug-Drug Interactions among Elderly Outpatients in the Piedmont Region (Italy): A Population-Based Study

  2022cites this paper
• Developing A Deep Learning Natural Language Processing Algorithm For Automated Reporting Of Adverse Drug Reactions

  2021cites this paper
• Just a Reflection: Does Drug Repurposing Perpetuate Sex-Gender Bias in the Safety Profile?

  2021cites this paper
• Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database

  2021influential citation
• Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source

  2021cites this paper
• Drug-Related Deaths in a Tertiary Hospital: Characteristics of Spontaneously Reported Cases and Comparison to Cases Detected from a Retrospective Study

  2021influential citation
• The Person’s Care Requires a Sex and Gender Approach

  2021influential citation
• Utilizing Transformers with Domain-Specific Pretraining and Active Learning to Enable Mining of Product Labels

  year unknowncites this paper